⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29441195 | 1.00 | — | — | |
| SCHEMBL10876938 | 0.93 | — | — | |
| SCHEMBL16369916 | 0.91 | MAPT (0.32) | — | |
| SCHEMBL16369918 | 0.91 | MAPT (0.32) | — | |
| SCHEMBL16369919 | 0.91 | MAPT (0.32) | — | |
| SCHEMBL2810066 | 0.81 | — | — | |
| SCHEMBL29813212 | 0.81 | — | — | |
| SCHEMBL15568681 | 0.81 | — | — | |
| SCHEMBL29147410 | 0.79 | — | — | |
| SCHEMBL12011138 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954990-A | Titanium catalyst component for ethylene polymerization, catalyst, preparation and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119954990-A | Titanium catalyst component for ethylene polymerization, catalyst, preparation and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4536356-A1 | PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | Xenon Pharmaceuticals Inc. (CA) | 2025-04-16 | — | — | EP | disclosed |
| US-20240317706-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS AG (CH) | 2024-09-26 | — | — | US | disclosed |
| US-11999699-B2 | Substituted pyrazole amides | Grünenthal GmbH (DE) | 2024-06-04 | — | — | US | disclosed |
| US-20240174662-A1 | SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES | CILAG AG (CH) | 2024-05-30 | — | — | US | disclosed |
| US-20240101531-A1 | PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | XENON PHARMACEUTICALS INC. (CA) | 2024-03-28 | — | — | US | disclosed |
| EP-4329757-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | Amgen Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023239729-A1 | PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | XENON PHARMACEUTICALS INC. (CA) | 2023-12-14 | — | — | WO | disclosed |
| EP-4284802-A1 | SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES | Janssen Biotech, Inc. (US) | 2023-12-06 | — | — | EP | disclosed |
| US-8598155-B2 | Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders | PFIZER INC. (US) | 2013-12-03 | — | — | US | disclosed |
| WO-2013061004-A1 | NOVEL DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED DISEASES | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2013-05-02 | — | — | WO | disclosed |
| WO-2013061004-A1 | NOVEL DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED DISEASES | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2013-05-02 | — | — | WO | disclosed |
| CN-102822172-A | Substituted naphthyridines and their use as syk kinase inhibitors | BOEHRINGER INGELHEIM INT | 2012-12-12 | — | — | CN | disclosed |
| US-20120214791-A1 | Imidazo[5,1-f][1,2,4]Triazines for the Treatment of Neurological Disorders | PFIZER INC. | 2012-08-23 | — | — | US | disclosed |
| US-7960407-B2 | Crystal forms of an imidazole derivative | REQUALIA PHARMA INC. (JP) | 2011-06-14 | — | — | US | disclosed |
| EP-1861400-B1 | CRYSTAL FORMS OF AN IMIDAZOLE DERIVATIVE | RAQUALIA PHARMA INC (JP) | 2010-05-26 | — | — | EP | disclosed |
| US-20090018158-A1 | CRYSTAL FORMS OF AN IMIDAZOLE DERIVATIVE | ASKAT INC. (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1861400-A1 | CRYSTAL FORMS OF AN IMIDAZOLE DERIVATIVE | Pfizer, Inc. (US) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006095268-A1 | CRYSTAL FORMS OF AN IMIDAZOLE DERIVATIVE | PFIZER JAPAN INC. (JP) | 2006-09-14 | — | — | WO | disclosed |